PRINCIPALES PUBLICATIONS SCIENTIFIQUES DEPUIS 2020
 

Capture d’écran 2022-11-20 à 20.00.00.png

de Ternay J, Larrieu A, Sauvestre L, Montègue S, Guénin M, Icard C, Rolland B. Insufficient physical activity is a global marker of severity in alcohol use disorder: results from a cross-sectional study in 382 treatment-seeking patients. Nutrients. 2022; 14(23), 4958; doi.org/10.3390/nu14234958

IF 6.7

Alcohol.jpg

Bolstad I, Toft H, Lien L, Moe JS, Rolland B, Bramness JG. Longitudinal determinants of insomnia among patients with alcohol use disorder.  Alcohol. 2022; S0741-8329(22)00116-1. doi: 10.1016/j.alcohol.2022.11.002.

IF 2.6

harm_reduction_journal.jpeg

de Ternay J, Leblanc P, Michel P, Benyamina A, Naassila M, Rolland B. One-month alcohol abstinence national campaigns: a scoping review of the harm reduction benefits. Harm Reduct J. 2022; 19(1):24. doi: 10.1186/s12954-022-00603-x

IF 4.8

J Psychopharmacol.jpg

Guiraud J, Addolorato G, Antonelli M, Aubin HJ, [...], Rolland B, Rotondo C, Scherrer B, Simon N, Skala K, Söderpalm B, Somaini L, Sommer WH, Spanagel R, Vassallo GA, Walter H, van den Brink W. Sodium oxybate for the maintenance of abstinence in alcohol-dependent patients: An international, multicenter, randomized, double-blind, placebo-controlled trial.
J Psychopharmacol.
2022; 36(10):1136-1145. doi: 10.1177/02698811221104063.

IF 4.2

SMR.jpg

Catoire S, Nourredine M, Lefebvre S, Couraud S, Gronfier C, Rey R, Peter-Derex L, Geoffroy PA, Rolland B. Tobacco-induced sleep disturbances: A systematic review and meta-analysis. Sleep Med Rev. 2021; 60:101544. doi: 10.1016/j.smrv.2021.101544.

IF 11.4

Dove press.jpg

Chappuy M, Meroueh F, Trojak B, Bachellier J, Bendimerad P, Kosim M, Hjelmström P, Nubukpo P, Brousse G, Rolland B. Factors of Interest in Extended-Release Buprenorphine: Comparisons Between Incarcerated and Non-Incarcerated Patients with Opioid Use Disorder.
Patient Prefer Adherence. 2021; 15:1259-1267. doi: 10.2147/PPA.S311674.

IF 2.1

EAR_Cover.png

Laconi S, Palma-Alvarez RF, Stöver H, Padberg C, Jamin D, Meroueh F, Chappuy M, Roncero C, Rolland B. Validation of the Opioid Overdose Knowledge (OOKS) and Attitudes (OOAS) Scales in French, Spanish, and German Languages, among a Sample of Opioid Users.
Eur Addict Res. 2021; 27(5):326-331. doi: 10.1159/000511770.

IF 4.0

JAMA_Psychiatry.png

Nourredine M, Gering A, Fourneret P, Rolland B, Falissard B, Cucherat M, Geoffray MM, Jurek L. Association of Attention-Deficit/Hyperactivity Disorder in Childhood and Adolescence With the Risk of Subsequent Psychotic Disorder: A Systematic Review and Meta-analysis
JAMA Psychiatry. 2021; 78(5):519-529. doi: 10.1001/jamapsychiatry.2020.4799.

IF 26.9

EOP.jpeg

Geoffroy PA, Lejoyeux M, Rolland B. Management of insomnia in alcohol use disorder. Expert Opin Pharmacother. 2020; 21(3):297-306. doi: 10.1080/14656566.2019.1705279.

IF 4.1

Progress in Neuropsychopharmacology.jpg

Meyrel M, Rolland B, Geoffroy PA. Management of insomnia in alcohol use disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2020; 99:109831. doi: 10.1016/j.pnpbp.2019.109831.

IF 4.6

Capture d'écran 2019-10-29 20.59.51.png

Rolland B, Simon N, Franchitto N, Aubin HJFrance Grants an Approval to Baclofen for Alcohol Dependence. Alcohol Alcohol. 2020; 55(1):44-45. doi: 10.1093/alcalc/agz082.

IF 3.9

Capture d'écran 2019-10-29 20.59.51.png

Pignon B, Sescousse G, Amad A, Benradia I, Vaiva G, Thomas P, Geoffroy PA, Roelandt JL, Rolland BAlcohol Use Disorder Is Differently Associated With Psychotic Symptoms According To Underlying Psychiatric Disorders: A General Population Study. Alcohol Alcohol. 2020; 55(1):112-120

IF 3.9